BCL2L2 and Alzheimer disease: An experimental part of the previously mentioned study proved that miRNA-29b overexpression was involved in the epidermal barrier dysfunction in AD, based on mediating γIFN-induced keratinocyte apoptosis via negative regulation of BcL2L2, an anti-apoptotic protein, contributing to the development of AD [30].